lazabemide has been researched along with toloxatone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Legoabe, LJ; Petzer, A; Petzer, JP | 1 |
| Alcaro, F; Alcaro, S; Carradori, S; Chimenti, P; Costa, G; De Monte, C; Gidaro, MC; Mannina, L; N'Da, CI; Petzer, A; Petzer, JP; Secci, D | 1 |
| Abramov, IG; Chirkova, ZV; Filimonov, SI; Firgang, SI; Kabanova, MV; Petzer, A; Petzer, JP; Suponitsky, KY | 1 |
| Lourens, AC; Minders, C; Petzer, A; Petzer, JP | 1 |
| Mostert, S; Petzer, A; Petzer, JP | 2 |
| Abramov, IG; Chirkova, ZV; Filimonov, SI; Kabanova, MV; Petzer, A; Petzer, JP; Suponitsky, KY | 1 |
| Kang, MG; Kim, H; Lee, HW; Oh, SR; Park, D; Ryu, HW | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Kim, SH; Lee, HW; Oh, SR; Park, D; Ryu, HW | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Oh, SR; Park, D; Ryu, HW | 1 |
| Legoabe, LJ; Petzer, A; Petzer, JP; Qhobosheane, MA | 1 |
| Baykov, S; Chirkova, Z; Engelbrecht, I; Korsakov, M; Osipyan, A; Petzer, A; Petzer, JP; Sapegin, A; Shetnev, A | 1 |
| Annie Rilda, PR; Baek, SC; Grace Thomas Parambi, D; Inasu, ST; Joy, M; Kim, H; Kumar Krishnan, G; Lohidakshan, KK; Mathew, B; Mathew, GE; Nithyamol, P; Pil Lee, J; Randev, RV; Vijayan, V | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Lee, JP; Oh, SR; Park, CM; Park, D; Park, JE; Ryu, HW | 1 |
| Efimova, J; Ivanovskii, S; Petzer, A; Petzer, JP; Shetnev, A; Shlenev, R; Tarasov, A | 1 |
15 other study(ies) available for lazabemide and toloxatone
| Article | Year |
|---|---|
α-Tetralone derivatives as inhibitors of monoamine oxidase.
Topics: Enzyme Activation; Humans; Models, Molecular; Monoamine Oxidase Inhibitors; Structure-Activity Relationship; Tetralones | 2014 |
New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.
Topics: Crocus; Crystallography, X-Ray; Cyclohexenes; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Plant Structures; Structure-Activity Relationship; Terpenes | 2014 |
Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.
Topics: Crystallography, X-Ray; Humans; Indoles; Kinetics; Molecular Conformation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Protein Binding; Protein Isoforms; Structure-Activity Relationship | 2015 |
Monoamine oxidase inhibitory activities of heterocyclic chalcones.
Topics: Antiparkinson Agents; Chalcones; HeLa Cells; Humans; Hydrocarbons, Fluorinated; Kinetics; Kynuramine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrroles; Structure-Activity Relationship; Thiophenes | 2015 |
Inhibition of monoamine oxidase by benzoxathiolone analogues.
Topics: Benzoxazoles; Humans; Inhibitory Concentration 50; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Protein Isoforms; Structure-Activity Relationship | 2016 |
An evaluation of synthetic indole derivatives as inhibitors of monoamine oxidase.
Topics: Crystallography, X-Ray; Models, Molecular; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2016 |
Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
Topics: Anthraquinones; Cell Line; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2017 |
The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
Topics: Benzoquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2017 |
Selective inhibition of monoamine oxidase A by hispidol.
Topics: Benzofurans; Binding Sites; Clorgyline; Flavonoids; Humans; Inhibitory Concentration 50; Kinetics; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazolidinones; Picolinic Acids | 2018 |
Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
Topics: Benzophenanthridines; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2018 |
Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Topics: Chemistry Techniques, Synthetic; Humans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Quinazolinones; Structure-Activity Relationship | 2018 |
Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
Topics: Dose-Response Relationship, Drug; Humans; Imidazoles; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Structure-Activity Relationship | 2019 |
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors.
Topics: | 2018 |
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Topics: Acetylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Enzyme Assays; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Structure-Activity Relationship | 2019 |
1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B.
Topics: Amino Acid Sequence; Antidepressive Agents; Benzenesulfonamides; Benzoates; Binding Sites; Drug Evaluation, Preclinical; Humans; Isomerism; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Protein Binding; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Zonisamide | 2019 |